These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18805842)

  • 1. Cognitive impairment in multiple sclerosis.
    Patti F
    Mult Scler; 2009 Jan; 15(1):2-8. PubMed ID: 18805842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment and rehabilitation of cognitive impairment in multiple sclerosis.
    Messinis L; Kosmidis MH; Lyros E; Papathanasopoulos P
    Int Rev Psychiatry; 2010; 22(1):22-34. PubMed ID: 20233112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI.
    Penner IK; Kappos L; Rausch M; Opwis K; Radü EW
    J Physiol Paris; 2006 Jun; 99(4-6):455-62. PubMed ID: 16713204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cognitive impairment in patients with multiple sclerosis.
    Patti F
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1679-99. PubMed ID: 22876911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cognitive and emotional disorders in multiple sclerosis. Can a management strategy be envisioned?].
    Pelletier J; Benoit N; Montreuil M; Habib M
    Pathol Biol (Paris); 2000 Mar; 48(2):121-31. PubMed ID: 10815288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there protective treatments for cognitive decline in MS?
    Amato MP; Portaccio E; Zipoli V
    J Neurol Sci; 2006 Jun; 245(1-2):183-6. PubMed ID: 16643949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive impairment].
    Reuter F; Audoin B; Rico A; Malikova I; Ranjeva JP; Pelletier J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction in multiple sclerosis: the effect of pharmacological interventions.
    Lyros E; Messinis L; Papageorgiou SG; Papathanasopoulos P
    Int Rev Psychiatry; 2010; 22(1):35-42. PubMed ID: 20222786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in different MS subtypes and clinically isolated syndromes.
    Potagas C; Giogkaraki E; Koutsis G; Mandellos D; Tsirempolou E; Sfagos C; Vassilopoulos D
    J Neurol Sci; 2008 Apr; 267(1-2):100-6. PubMed ID: 17997417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing the symptoms of multiple sclerosis: a multimodal approach.
    Crayton HJ; Rossman HS
    Clin Ther; 2006 Apr; 28(4):445-60. PubMed ID: 16750459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.
    Glanz BI; Holland CM; Gauthier SA; Amunwa EL; Liptak Z; Houtchens MK; Sperling RA; Khoury SJ; Guttmann CR; Weiner HL
    Mult Scler; 2007 Sep; 13(8):1004-10. PubMed ID: 17623735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive impairment in the early phase of multiple sclerosis and its relationship with mood, demographic and clinical variables].
    Nieto Barco A; Sánchez López Mdel P; Barroso Ribal J; Olivares Pérez T; Hernández Pérez MA
    Psicothema; 2008 Nov; 20(4):583-8. PubMed ID: 18940054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
    Denney DR; Lynch SG; Parmenter BA
    J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI correlates of cognitive dysfunction in multiple sclerosis patients.
    Rovaris M; Filippi M
    J Neurovirol; 2000 May; 6 Suppl 2():S172-5. PubMed ID: 10871808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.